companiesCompany
Vevo Therapeutics
Produced Tahoe-100M, the largest single-cell drug-perturbation atlas, and trains models on it.
Tahoe-100M (2025): 100 million single-cell profiles across 1,100 drugs and 50 cancer cell lines, generated with its Mosaic platform and released openly with Parse Biosciences and Arc Institute.